Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Verona reports part one data from phase II trial of DPI formulation of ensifentrine in COPD

March 4, 2019

Bayer presents novel adenosine A2B receptor antagonist with potential for lung fibrosis

Feb. 28, 2019

Detailed results from phase III trials of Dupixent in chronic rhinosinusitis with nasal polyps

Feb. 26, 2019

Calithera initiates phase I study of the arginase inhibitor CB-280

Feb. 22, 2019

GlaxoSmithKline Intellectual Property divulges PI3K inhibitors

Feb. 20, 2019

GlaxoSmithKline describes discovery of sulforaphane analogues for COPD

Feb. 18, 2019

Bridge Biotherapeutics recruiting participants in first-in-human study of BBT-877

Feb. 18, 2019

Vertex presents positive phase III study data for tezacaftor/ivacaftor

Feb. 15, 2019

Medshine Discovery presents Rho kinase inhibitors

Feb. 4, 2019

Bayer and Kyoto University form new research alliance in pulmonology

Feb. 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.